Doximity, Inc. $DOCS Shares Sold by Lmcg Investments LLC

Key Points

• Lmcg Investments LLC reduced its stake in Doximity, Inc. by 5.3% during the second quarter, holding 112,174 shares valued at approximately $6.88 million.
• Doximity recently reported $0.36 earnings per share for the latest quarter, surpassing estimates and showing a 15.2% increase in year-over-year revenue.
• Institutional investors own 87.19% of Doximity's stock, with analysts offering an average price target of $69.37 and multiple analyst upgrades recently.

Lmcg Investments LLC trimmed its stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 5.3% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 112,174 shares of the company's stock after selling 6,223 shares during the quarter. Lmcg Investments LLC owned about 0.06% of Doximity worth $6,881,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Vanguard Group Inc. lifted its position in Doximity by 8.8% during the 1st quarter. Vanguard Group Inc. now owns 12,194,492 shares of the company's stock worth $707,646,000 after acquiring an additional 990,923 shares during the period. Invesco Ltd. lifted its holdings in shares of Doximity by 54.8% in the 1st quarter. Invesco Ltd. now owns 1,969,326 shares of the company's stock valued at $114,280,000 after buying an additional 696,923 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Doximity by 130.4% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,966,801 shares of the company's stock valued at $114,133,000 after buying an additional 1,113,076 shares during the period. Fuller & Thaler Asset Management Inc. lifted its holdings in shares of Doximity by 9.5% in the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 1,730,282 shares of the company's stock valued at $100,408,000 after buying an additional 150,574 shares during the period. Finally, Bank of New York Mellon Corp lifted its holdings in shares of Doximity by 8.2% in the 1st quarter. Bank of New York Mellon Corp now owns 1,137,912 shares of the company's stock valued at $66,033,000 after buying an additional 86,135 shares during the period. 87.19% of the stock is owned by institutional investors and hedge funds.

Doximity Price Performance

NASDAQ DOCS opened at $65.70 on Friday. The business has a 50 day moving average price of $68.46 and a 200 day moving average price of $60.96. The company has a market capitalization of $12.31 billion, a P/E ratio of 65.70, a PEG ratio of 4.10 and a beta of 1.38. Doximity, Inc. has a 1-year low of $40.87 and a 1-year high of $85.21.

Doximity (NASDAQ:DOCS - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.The firm's revenue for the quarter was up 15.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.28 earnings per share. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. On average, research analysts expect that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have recently commented on the company. Truist Financial raised their price target on Doximity from $52.00 to $61.00 and gave the company a "hold" rating in a report on Thursday, July 17th. Needham & Company LLC raised their price target on Doximity from $67.00 to $75.00 and gave the company a "buy" rating in a report on Friday, August 8th. Bank of America raised their price target on Doximity from $55.00 to $62.00 and gave the company a "neutral" rating in a report on Wednesday, June 25th. KeyCorp raised their price target on Doximity from $75.00 to $80.00 and gave the company an "overweight" rating in a report on Wednesday. Finally, Piper Sandler raised their price target on Doximity from $65.00 to $69.00 and gave the company an "overweight" rating in a report on Monday, August 11th. One investment analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, nine have assigned a Hold rating and two have assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $69.37.

Insiders Place Their Bets

In other Doximity news, Director Kira Scherer Wampler sold 2,000 shares of the firm's stock in a transaction on Friday, August 1st. The stock was sold at an average price of $57.09, for a total transaction of $114,180.00. Following the completion of the transaction, the director owned 16,618 shares of the company's stock, valued at approximately $948,721.62. This trade represents a 10.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Regina M. Benjamin sold 5,000 shares of the firm's stock in a transaction on Friday, September 12th. The stock was sold at an average price of $70.50, for a total value of $352,500.00. Following the transaction, the director directly owned 19,839 shares of the company's stock, valued at $1,398,649.50. The trade was a 20.13% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 32,000 shares of company stock valued at $2,281,680. Corporate insiders own 31.30% of the company's stock.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.